| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2000;119:155-162
© 2000 Mosby, Inc.
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY |
From the Departments of Cardiology and Anesthesia,b Children’s Hospital, Boston, and the Departments of Pediatrics and Anesthesia,a Harvard Medical School, Boston, Mass.
Supported in part by funds from the Nova Biomedical Corporation (Waltham, Mass) and the Boston Children’s Heart Foundation.
Presented at the Forty-eighth Annual Scientific Session of the American College of Cardiology, New Orleans, La, March 7-10, 1999.
Address for reprints: Ricardo Munoz, MD, Cardiac ICU Office, FA-105, Children’s Hospital, 300 Longwood Ave, Boston, MA 02115 (E-mail: munoz_r{at}a1.tch.harvard.edu).
Objective: Our objective was to evaluate the change in lactate level during cardiopulmonary bypass and the possible predictive value in identifying patients at high risk of morbidity and mortality after surgery for congenital cardiac disease.
Methods: We prospectively studied lactate levels in 174 nonconsecutive patients undergoing cardiopulmonary bypass during operations for congenital cardiac disease. Arterial blood samples were taken before cardiopulmonary bypass, during cardiopulmonary bypass (cooling and rewarming), after cardiopulmonary bypass, and during admission to the cardiac intensive care unit. Complicated outcomes were defined as open sternum as a response to cardiopulmonary instability, renal failure, cardiac arrest and resuscitation, extracorporeal membrane oxygenation, and death.
Results: The largest increment in lactate level occurred during cardiopulmonary bypass. Lactate levels decreased between the postbypass period and on admission to the intensive care unit. Patients who had circulatory arrest exhibited higher lactate levels at all time points. Nonsurvivors had higher lactate levels at all time points. A change in lactate level of more than 3 mmol/L during cardiopulmonary bypass had the optimal sensitivity (82%) and specificity (80%) for mortality, although the positive predictive value was low.
Conclusions: Hyperlactatemia occurs during cardiopulmonary bypass in patients undergoing operations for congenital cardiac disease and may be an early indicator for postoperative morbidity and mortality.
This article has been cited by other articles:
|
|
 |
|
  R. B.M. Hosein, K. P. Morris, W. J. Brawn, and D. J. Barron Use of tissue microdialysis to investigate hyperlactataemia following paediatric cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 384 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyamoto, N. Sinzobahamvya, J. Photiadis, A. M Brecher, and B. Asfour Survival after Surgery with Cardiopulmonary Bypass in Low Weight Patients Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 115 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Murray, D. Grant, N. Murali, and W. Butt Unmeasured anions in children after cardiac surgery J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 235 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Mildh, V. Pettila, H. I. Sairanen, and P. H. Rautiainen Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery Ann. Thorac. Surg., November 1, 2006; 82(5): 1643 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hickey, T. Karamlou, J. You, and R. M. Ungerleider Effects of Circuit Miniaturization in Reducing Inflammatory Response to Infant Cardiopulmonary Bypass by Elimination of Allogeneic Blood Products Ann. Thorac. Surg., June 1, 2006; 81(6): S2367 - S2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 632 - 638.
|
|
|
|
|
|
R. L. Hannan, M. A. Ybarra, J. A. White, J. W. Ojito, A. F. Rossi, and R. P. Burke Patterns of Lactate Values after Congenital Heart Surgery and Timing of Cardiopulmonary Support Ann. Thorac. Surg., October 1, 2005; 80(4): 1468 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Cheung, N. Chui, A. R. Joffe, I. M. Rebeyka, C. M.T. Robertson, and Western Canadian Complex Pediatric Therapies Proje Postoperative lactate concentrations predict the outcome of infants aged 6 weeks or less after intracardiac surgery: A cohort follow-up to 18 months J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H Schroeder and M. Hansen Effects of fresh versus old stored blood in the priming solution on whole blood lactate levels during paediatric cardiac surgery Perfusion, January 1, 2005; 20(1): 17 - 19. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Lequier Extracorporeal Life Support in Pediatric and Neonatal Critical Care: A Review J Intensive Care Med, September 1, 2004; 19(5): 243 - 258. [Abstract] [PDF]
|
|
|
|
|
|
Y. Ootaki, M. Yamaguchi, N. Yoshimura, S. Oka, M. Yoshida, and T. Hasegawa Efficacy of a criterion-driven transfusion protocol in patients having pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 953 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Tibby and I A Murdoch Monitoring cardiac function in intensive care Arch. Dis. Child., January 1, 2003; 88(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sason-Ton, R. Ben Abraham, D. Lotan, O. Dagan, T. Prince, Z. Barzilay, and G. Paret Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 991 - 998. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
